Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

March 01, 2009 (Vol. 29, No. 5)

Clinical Proteomics Heads Into Real World

Improved Instrumentation and Unbiased Samples Renew Promise of Biomarker Pipeline

  • Given that proteins are the primary working parts of cells, it seems self-evident that proteomics should yield abundant clues to disease mechanisms, as well as numerous clinically useful biomarkers. Biomarkers in readily accessible bodily fluids such as plasma, in particular, offer the potential for rapid advances in patient care ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.